Izurieta HS - Search Results

1

Hospital-based collaboration for epidemiological investigation of vaccine safety: A potential solution for low and middle-income countries?

Izurieta HS, Moro PL, Chen RT. Izurieta HS, et al. Vaccine. 2018 Jan 8;36(3):345-346. doi: 10.1016/j.vaccine.2017.10.003. Epub 2017 Oct 21. Vaccine. 2018. PMID: 29033065 Free PMC article. No abstract available.

2

Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines.

Izurieta HS, Zuber P, Bonhoeffer J, Chen RT, Sankohg O, Laserson KF, Sturkenboom M, Loucq C, Weibel D, Dodd C, Black S. Izurieta HS, et al. Vaccine. 2013 Aug 2;31(35):3623-7. doi: 10.1016/j.vaccine.2013.05.027. Epub 2013 May 21. Vaccine. 2013. PMID: 23707171

3

ADVANCE: The promises, pitfalls, and future prospects of a European distributed data network for immunization surveillance and research.

DeStefano F, Chen RT, Izurieta HS, Raine JM. DeStefano F, et al. Among authors: izurieta hs. Vaccine. 2020 Dec 22;38 Suppl 2(Suppl 2):v-vi. doi: 10.1016/j.vaccine.2020.12.029. Vaccine. 2020. PMID: 33342487 Free PMC article. No abstract available.

4

A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination.

Verstraeten T, Jumaan AO, Mullooly JP, Seward JF, Izurieta HS, DeStefano F, Black SB, Chen RT; Vaccine Safety Datalink Research Group. Verstraeten T, et al. Among authors: izurieta hs. Pediatrics. 2003 Aug;112(2):e98-103. doi: 10.1542/peds.112.2.e98. Pediatrics. 2003. PMID: 12897314

5

Application of the immunological disease continuum to study autoimmune and other inflammatory events after vaccination.

Koenig HC, Sutherland A, Izurieta HS, McGonagle D. Koenig HC, et al. Among authors: izurieta hs. Vaccine. 2011 Jan 29;29(5):913-9. doi: 10.1016/j.vaccine.2010.10.044. Epub 2010 Oct 29. Vaccine. 2011. PMID: 21036134 Review.

6

Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.

Arya DP, Said MA, Izurieta HS, Perez-Vilar S, Zinderman C, Wernecke M, Alexander M, White T, Su IH, Lufkin B, MaCurdy T, Kelman J, Forshee R. Arya DP, et al. Among authors: izurieta hs. Vaccine. 2019 Oct 8;37(43):6543-6549. doi: 10.1016/j.vaccine.2019.08.045. Epub 2019 Sep 9. Vaccine. 2019. PMID: 31515146

7

Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005.

Dobardzic A, Izurieta H, Woo EJ, Iskander J, Shadomy S, Rupprecht C, Ball R, Braun MM. Dobardzic A, et al. Vaccine. 2007 May 22;25(21):4244-51. doi: 10.1016/j.vaccine.2007.02.075. Epub 2007 Mar 15. Vaccine. 2007. PMID: 17382435 Clinical Trial.

8

Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis.

Korves C, Izurieta HS, Smith J, Zwain GM, Powell EI, Balajee A, Ryder KM, Young-Xu Y. Korves C, et al. Among authors: izurieta hs. Vaccine. 2022 Aug 5;40(33):4742-4747. doi: 10.1016/j.vaccine.2022.06.047. Epub 2022 Jun 21. Vaccine. 2022. PMID: 35773122 Free PMC article.

9

Facial nerve palsy including Bell's palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data.

Rath B, Gidudu JF, Anyoti H, Bollweg B, Caubel P, Chen YH, Cornblath D, Fernandopulle R, Fries L, Galama J, Gibbs N, Grilli G, Grogan P, Hartmann K, Heininger U, Hudson MJ, Izurieta HS, Jevaji I, Johnson WM, Jones J, Keller-Stanislawski B, Klein J, Kohl K, Kokotis P, Li Y, Linder T, Oleske J, Richard G, Shafshak T, Vajdy M, Wong V, Sejvar J; Brighton Collaboration Bell's Palsy Working Group. Rath B, et al. Among authors: izurieta hs. Vaccine. 2017 Apr 4;35(15):1972-1983. doi: 10.1016/j.vaccine.2016.05.023. Epub 2016 May 24. Vaccine. 2017. PMID: 27235092 No abstract available.

10

Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Gershman MD, Staples JE, Bentsi-Enchill AD, Breugelmans JG, Brito GS, Camacho LA, Cottin P, Domingo C, Durbin A, Gascon J, Guenaneche F, Hayes EB, Jelenik Z, Khromava A, Martins Rde M, Wilson MM, Massy N, Nasidi A, Niedrig M, Sherwat A, Tsai T, Vilella A, Wilson ME, Kohl KS; Brighton Collaboration Viscerotropic Disease Working Group. Gershman MD, et al. Vaccine. 2012 Jul 13;30(33):5038-58. doi: 10.1016/j.vaccine.2012.04.067. Epub 2012 May 4. Vaccine. 2012. PMID: 22561144 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page